arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

Korro Bio, Inc.

KRRO

$13.22 ▲ +1.04 (+8.54%) at close

9 Visible periods

26 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, Korro Bio, Inc. shows weak fundamentals, weighed down by FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $124.2M

Dividend Yield —

Revenue Growth 181.5%

Op. Margin None

ROIC None

FCF / Share $-8.42 ↗

Trailing P/E —

Price / Book —

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 7, 2026.

9-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$6.39M

↑ +181.5% —

Net Income Profit after all expenses

$-117.26M

↓ -40.3% —

Operating Margin Operating profit as % of sales

-74.5%

↓ -4.3% —

FCF / Share Free cash flow per share

$-8.42

↑ +3.7% —

Long-Term Debt Long-term obligations

$180.00K

↓ -48.4% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

FCF / Net IncomeFCF / Net Income of 0.67x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue Growth YoY (%)	181.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2168%)	—	—	N/M	-62.0% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-875%)	27.8% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+247%)	—	—	—
EPS Growth YoY (%)	-33.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	82.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-40.3% Weak ↓ Weak Declining Year-over-year change in net income	-3.0% Weak ↑ Weak Improving Year-over-year change in net income	0.5% Caution ↑ Caution Improving Year-over-year change in net income	3.7% Caution ↑ Caution Improving Year-over-year change in net income	-219.4% Weak ↓ Weak Declining Year-over-year change in net income	-41.4% Weak ↓ Weak Declining Year-over-year change in net income	2.2% Caution Caution Year-over-year change in net income	5.3% Fair Fair Year-over-year change in net income	—
FCF Growth YoY (%)	3.7% Caution Caution Year-over-year change in free cash flow	82.2% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	-45.6% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—
Revenue CAGR 5Y (%)	-29.6% Weak Weak Compound annual revenue growth over 5 years	-39.9% Weak Weak Compound annual revenue growth over 5 years	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	-74.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-597%)	-71.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-576%)	—	—
Effective Tax Rate (%) (%)	-0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—
Profit Margin (%) (%)	—	—	—	—	—	-71.7% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-697%)	-64.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-640%)	—	—
FCF Margin (%) (%)	—	—	—	—	—	-140.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	114.5% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.67x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.93x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	1.96x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	-1.77x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.91x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution Caution Free cash flow relative to reported net income Optimal: > 1x

🎯 Is capital allocation efficient? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	—	—	—	—	—	—	-11486.1% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	-4288.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-107.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-38.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-68.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-45.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	-42.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—

⚖️ Is the balance sheet risky? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Interest Coverage (x)	—	—	—	-86.37x Weak Weak Operating income divided by interest expense Optimal: > 5x	-109.99x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-178.72x Weak Weak Operating income divided by interest expense Optimal: > 5x	-93.71x Weak Weak Operating income divided by interest expense Optimal: > 5x
Net Debt (USD)	$-21.82M	$-55.64M	$-36.60M	$-51.95M	$-79.64M	$-220.34M	$-199.98M	$-41.84M	—
Debt / EBITDA (x)	—	—	—	—	—	—	-0.01x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.02x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—

📊 What does each share earn? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Revenue per Share (USD)	$0.68	$0.25	$0.00	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-12.48	$-9.37	$-53.08	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-8.42	$-8.74	$-49.12	—	—	—	—	—	—
Basic Weighted Avg Shares (shares)	9.40M	8.92M	1.53M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$70.44M	$116.57M	$153.25M	$66.47M	$123.32M	$198.43M	$168.57M	$39.16M	—
LT Debt (USD)	—	—	—	—	—	—	$180.00K	$349.00K	—

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2023 10-K ↗	FY 2022 Dec 31, 2022 10-K ↗	FY 2021 Dec 31, 2021 10-K ↗	FY 2020 Dec 31, 2020 10-K ↗	FY 2019 Dec 31, 2019 10-K ↗	FY 2018 Dec 31, 2018 10-K ↗	FY 2017 Dec 31, 2017 10-K ↗
Sales/Revenue/Turnover (USD)	$6.39M	$2.27M	$0.00	$0.00	$14.07M	$36.98M	$28.95M	—	—
Depreciation Expense (USD)	$4.28M	$3.56M	$3.63M	$2.77M	$2.77M	$1.15M	$813.00K	$654.00K	$531.00K
Net Income, GAAP (USD)	$-117.26M	$-83.58M	$-81.17M	$-81.58M	$-84.69M	$-26.51M	$-18.75M	$-19.17M	$-20.24M
Operating Cash Flow (USD)	$-78.56M	$-60.07M	$-67.28M	$-58.24M	$-76.06M	$-45.19M	$34.22M	$-17.02M	$-14.61M

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 31 quarters

Korro Bio, Inc.

Analytical Summary

9-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare KRRO with peers